Skip Navigation


ToxSci Advance Access originally published online on April 14, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow All Versions of this Article:
80/1/14    most recent
kfh147v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (135)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mueller, S. O.
Right arrow Articles by Korach, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, S. O.
Right arrow Articles by Korach, K. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 80, 14-25 (2004)
Toxicological Sciences vol. 80 no. 1 © Society of Toxicology 2004; all rights reserved.

Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor {alpha} (ER{alpha}) and ERß in Human Cells

Stefan O. Mueller*,1, Stephanie Simon*, Kun Chae{dagger}, Manfred Metzler{ddagger} and Kenneth S. Korach{dagger}

* Molecular Toxicology, Institute of Toxicology, Merck KGaA, Darmstadt, Germany; {dagger} Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; and {ddagger} Institute of Food Chemistry and Toxicology, University of Karlsruhe, Karlsruhe, Germany

Received January 9, 2004; accepted April 5, 2004

Phytoestrogens exert pleiotropic effects on cellular signaling and show some beneficial effects on estrogen-dependent diseases. However, due to activation/inhibition of the estrogen receptors ER{alpha} or ERß, these compounds may induce or inhibit estrogen action and, therefore, have the potential to disrupt estrogen signaling. We performed a comprehensive analysis and potency comparison of phytoestrogens and their human metabolites for ER binding, induction/suppression of ER{alpha} and ERß transactivation, and coactivator recruitment in human cells. The soy-derived genistein, coumestrol, and equol displayed a preference for transactivation of ERß compared to ER{alpha} and were 10- to 100-fold less potent than diethylstilbestrol. In contrast, zearalenone was the most potent phytoestrogen tested and activated preferentially ER{alpha}. All other phytoestrogens tested, including resveratrol and human metabolites of daidzein and enterolactone, were weak ER agonists. Interestingly, the daidzein metabolites 3',4',7-isoflavone and 4',6,7-isoflavone were superagonists on ER{alpha} and ERß. All phytoestrogens tested showed reduced potencies to activate ER{alpha} and ERß compared to diethylstilbestrol on the estrogen-responsive C3 promoter compared to a consensus estrogen response element indicating a degree of promoter dependency. Zearalenone and resveratrol were antagonistic on both ER{alpha} and ERß at high doses. The phytoestrogens enhanced preferentially recruitment of GRIP1 to ER{alpha} similar to 17ß-estradiol. In contrast, for ERß no distinct preference for one coactivator (GRIP1 or SRC-1) was apparent and the overall coactivator association was less pronounced than for ER{alpha}. Due to their abundance and (anti)-estrogenic potencies, the soy-derived isoflavones, coumestrol, resveratrol, and zearalenone would appear to have the potential for effectively functioning as endocrine disruptors.

Key Words: ER{alpha}; ERß; xenoestrogen; endocrine disruptors; Ishikawa; coactivator recruitment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Nutr.Home page
S. Bolca, C. Wyns, S. Possemiers, H. Depypere, D. De Keukeleire, M. Bracke, W. Verstraete, and A. Heyerick
Cosupplementation of Isoflavones, Prenylflavonoids, and Lignans Alters Human Exposure to Phytoestrogen-Derived 17{beta}-Estradiol Equivalents
J. Nutr., December 1, 2009; 139(12): 2293 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E. Sonestedt, M. I. L. Ivarsson, S. Harlid, U. Ericson, B. Gullberg, J. Carlson, H. Olsson, H. Adlercreutz, and E. Wirfalt
The Protective Association of High Plasma Enterolactone with Breast Cancer Is Reasonably Robust in Women with Polymorphisms in the Estrogen Receptor {alpha} and {beta} Genes
J. Nutr., May 1, 2009; 139(5): 993 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. Pan, O. H. Franco, J. Ye, W. Demark-Wahnefried, X. Ye, Z. Yu, H. Li, and X. Lin
Soy Protein Intake Has Sex-Specific Effects on the Risk of Metabolic Syndrome in Middle-Aged and Elderly Chinese
J. Nutr., December 1, 2008; 138(12): 2413 - 2421.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, H. Olsson, H. Adlercreutz, G. Landberg, and E. Wirfalt
Enterolactone Is Differently Associated with Estrogen Receptor {beta}-Negative and -Positive Breast Cancer in a Swedish Nested Case-Control Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3241 - 3251.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, G. Landberg, H. Olsson, and E. Wirfalt
Plant foods and oestrogen receptor {alpha}- and {beta}-defined breast cancer: observations from the Malmo Diet and Cancer cohort
Carcinogenesis, November 1, 2008; 29(11): 2203 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Luciani, C. Deledda, F. Rosati, S. Benvenuti, I. Cellai, F. Dichiara, M. Morello, G. B. Vannelli, G. Danza, M. Serio, et al.
Seladin-1 Is a Fundamental Mediator of the Neuroprotective Effects of Estrogen in Human Neuroblast Long-Term Cell Cultures
Endocrinology, September 1, 2008; 149(9): 4256 - 4266.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
X. Di, L. Yu, A.B. Moore, L. Castro, X. Zheng, T. Hermon, and D. Dixon
A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells
Hum. Reprod., August 1, 2008; 23(8): 1873 - 1883.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. Hedelin, M. Lof, M. Olsson, H. Adlercreutz, S. Sandin, and E. Weiderpass
Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women
J. Nutr., May 1, 2008; 138(5): 938 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. Kuijsten, P. C. H. Hollman, H. C. Boshuizen, M. N. C. P. Buijsman, P. van 't Veer, F. J. Kok, I. C. W. Arts, and H. B. Bueno-de-Mesquita
Plasma Enterolignan Concentrations and Colorectal Cancer Risk in a Nested Case-Control Study
Am. J. Epidemiol., March 15, 2008; 167(6): 734 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
W. H. Xu, Q. Dai, Y. B. Xiang, J. R. Long, Z. X. Ruan, J. R. Cheng, W. Zheng, and X. O. Shu
Interaction of Soy Food and Tea Consumption with CYP19A1 Genetic Polymorphisms in the Development of Endometrial Cancer
Am. J. Epidemiol., December 15, 2007; 166(12): 1420 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. P. Konhilas and L. A. Leinwand
The Effects of Biological Sex and Diet on the Development of Heart Failure
Circulation, December 4, 2007; 116(23): 2747 - 2759.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Penttinen, J. Jaehrling, A. E. Damdimopoulos, J. Inzunza, J. G. Lemmen, P. van der Saag, K. Pettersson, G. Gauglitz, S. Makela, and I. Pongratz
Diet-Derived Polyphenol Metabolite Enterolactone Is a Tissue-Specific Estrogen Receptor Activator
Endocrinology, October 1, 2007; 148(10): 4875 - 4886.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Ray, F. Xu, P. Li, N. S. Sanchez, H. Wang, and S. K. Das
Increased Level of Cellular Bip Critically Determines Estrogenic Potency for a Xenoestrogen Kepone in the Mouse Uterus
Endocrinology, October 1, 2007; 148(10): 4774 - 4785.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Enokizono, H. Kusuhara, and Y. Sugiyama
Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens
Mol. Pharmacol., October 1, 2007; 72(4): 967 - 975.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. Chen, K. A. Power, J. Mann, A. Cheng, and L. U. Thompson
Flaxseed Alone or in Combination with Tamoxifen Inhibits MCF-7 Breast Tumor Growth in Ovariectomized Athymic Mice with High Circulating Levels of Estrogen
Experimental Biology and Medicine, September 1, 2007; 232(8): 1071 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. T. Akingbemi, T. D. Braden, B. W. Kemppainen, K. D. Hancock, J. D. Sherrill, S. J. Cook, X. He, and J. G. Supko
Exposure to Phytoestrogens in the Perinatal Period Affects Androgen Secretion by Testicular Leydig Cells in the Adult Rat
Endocrinology, September 1, 2007; 148(9): 4475 - 4488.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. E. Harper, B. B. Patel, J. Wang, A. Arabshahi, I. A. Eltoum, and C. A. Lamartiniere
Resveratrol suppresses prostate cancer progression in transgenic mice
Carcinogenesis, September 1, 2007; 28(9): 1946 - 1953.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. Blaut and T. Clavel
Metabolic Diversity of the Intestinal Microbiota: Implications for Health and Disease
J. Nutr., March 1, 2007; 137(3): 751S - 755S.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
L. A. Gilad, O. Tirosh, and B. Schwartz
Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells.
J. Endocrinol., November 1, 2006; 191(2): 387 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Widyarini, D. Domanski, N. Painter, and V. E. Reeve
Estrogen receptor signaling protects against immune suppression by UV radiation exposure
PNAS, August 22, 2006; 103(34): 12837 - 12842.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. V. Henley and K. S. Korach
Endocrine-Disrupting Chemicals Use Distinct Mechanisms of Action to Modulate Endocrine System Function
Endocrinology, June 1, 2006; 147(6): s25 - s32.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Bottner, J. Christoffel, H. Jarry, and W. Wuttke
Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats.
J. Endocrinol., April 1, 2006; 189(1): 77 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
N. V. Soucy, H. D. Parkinson, M. A. Sochaski, and S. J. Borghoff
Kinetics of Genistein and Its Conjugated Metabolites in Pregnant Sprague-Dawley Rats Following Single and Repeated Genistein Administration
Toxicol. Sci., March 1, 2006; 90(1): 230 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
O. Wada-Hiraike, O. Imamov, H. Hiraike, K. Hultenby, T. Schwend, Y. Omoto, M. Warner, and J.-A. Gustafsson
Role of estrogen receptor beta in colonic epithelium
PNAS, February 21, 2006; 103(8): 2959 - 2964.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. E. Wood, T. C. Register, A. A. Franke, M. S. Anthony, and J. M. Cline
Dietary Soy Isoflavones Inhibit Estrogen Effects in the Postmenopausal Breast
Cancer Res., January 15, 2006; 66(2): 1241 - 1249.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. E. Juan, E. Gonzalez-Pons, T. Munuera, J. Ballester, J. E. Rodriguez-Gil, and J. M. Planas
trans-Resveratrol, a Natural Antioxidant from Grapes, Increases Sperm Output in Healthy Rats
J. Nutr., April 1, 2005; 135(4): 757 - 760.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. J. Fabian and B. F. Kimler
Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer
J. Clin. Oncol., March 10, 2005; 23(8): 1644 - 1655.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.